Sientra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 04:03 pm
Share
Sientra, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 23.13 million compared to USD 21.51 million a year ago. Net loss was USD 9.48 million compared to USD 18.3 million a year ago. Basic loss per share from continuing operations was USD 0.85 compared to USD 2.91 a year ago. Basic loss per share was USD 0.85 compared to USD 2.92 a year ago.
For the six months, sales was USD 45.69 million compared to USD 42.91 million a year ago. Net loss was USD 22.37 million compared to USD 36.35 million a year ago. Basic loss per share from continuing operations was USD 1.93 compared to USD 5.8 a year ago. Basic loss per share was USD 1.93 compared to USD 5.82 a year ago.
Project Sage Oldco Inc., formerly Sientra, Inc., is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.